News

The 4th Renpower Ukraine Investors – Online Conference is set to take place online (live streaming) on January 27-28 (from 14.00 to 17.30 on both days, local time in Kiev). We would be happy to count you and your colleagues in this leading annual market event gathering developers, EPCs, manufacturers, technology suppliers, consulting, financiers, local stakeholders and IFIs in the most dedicated hub for business, innovation and knowledge exchange.

One of the strategic directions of the Network's activities for the next three years is strengthening the expertise and building partnerships with financial institutions in the field of compliance. To organize a professional discussion and develop the necessary legislative changes, UNIC initiated the creation of the Banking expert group, which included the best experts in this field.

Larysa has 8 years of professional GR experience as a National Advocacy Advisor in the International Charitable Organization “Charitable Foundation “SOS Children’s Villages” (Ukraine) and as a Coordinator of the advocacy-campaigns in «Ukrainian Philanthropists Forum» and extensive experience of work with public authorities.

From November 15 to December 15, the Ukrainian Network of Integrity and Compliance (UNIC) hosted the UNIC Business Integrity Month 2020, a unique event that brought together leading compliance and anti-corruption professionals from various countries all over the world.

We are pleased to announce that last week the Network held its first meeting with the Independent Association of Banks of Ukraine.

On November 12, 2020, a high-level discussion on “Reforming the State Tax Service through the Prism of Integrity of Taxpayers and Taxpayers” organized by the Ukrainian Network of Integrity and Compliance (UNIC) took place.

Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes).Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 150 countries and a turnover of 4.6 billion euros in 2019, Servier employs 22,000 people worldwide. Entirely independent, the Group reinvests in average 25% of its turnover (excluding generics) every year in research and development and uses all its profits for development. Corporate growth is driven by Servier’s constant commitment in five areas of excellence: cardiovascular, immune-inflammatory and neurodegenerative diseases, cancer and diabetes, as well as by its activities in high-quality generic drugs. Servier also offers eHealth solutions beyond drug development.